摘要
目的分析注射用阿奇霉素治疗小儿肺炎支原体感染急性气管-支气管炎的临床效果。方法选取2018年4月至2019年8月我院收治的72例肺炎支原体感染急性气管-支气管炎的患儿作为研究对象,按照信封抽号的方式将其分为常规组(红霉素治疗)和治疗组(注射用阿奇霉素治疗),每组36例。比较两组的治疗效果、症状消失时间以及不良反应发生情况。结果治疗组的治疗总有效率为94.44%,高于常规组的77.78%(P<0.05)。治疗组的咽部充血、发热以及咳嗽消失时间明显短于常规组(P<0.05)。治疗组的不良反应总发生率为5.56%,低于常规组的22.22%(P<0.05)。结论阿奇霉素在小儿肺炎支原体感染急性气管-支气管炎中的应用效果较好,可迅速缓解患儿的咳嗽等症状,且不良反应发生率低,值得推广应用。
Objective To analyze the clinical effect of azithromycin for injection in treatment of acute tracheo-bronchitis caused by Mycoplasma pneumoniae infection in children.Methods From April 2018 to August 2019,72 children with acute tracheo-bronchitis caused by Mycoplasma pneumoniae infection were selected as the study objects.The children were divided into routine group(erythromycin treatment)and treatment group(azithromycin for injection treatment),with 36 cases in each group.The therapeutic effects,symptom disappearance time and adverse reactions of the two groups were compared.Results The total effective rate of treatment in the treatment group was 94.44%,which was higher than 77.78%in the routine group(P<0.05).The disappearance times of pharyngeal congestion,fever and cough in the treatment group were significantly shorter than those in the routine group(P<0.05).The total incidence of adverse reactions in the treatment group was 5.56%,which was lower than 22.22%in the routine group(P<0.05).Conclusion Azithromycin in treatment of acute tracheo-bronchitis caused by Mycoplasma pneumoniae infection in children has a good effect,it can quickly relieve the cough and other symptoms,with low incidence of adverse reactions,which is worth promoting and applying.
作者
张丽
陈伟明
谢中勇
ZHANG Li;CHEN Wei-ming;XIE Zhong-yong(Huizhou Maternal and Child Health and Family Planning Service Center,Huizhou 516000,China)
出处
《临床医学研究与实践》
2020年第15期85-86,92,共3页
Clinical Research and Practice
关键词
注射用阿奇霉素
急性气管-支气管炎
肺炎支原体感染
红霉素
azithromycin for injection
acute tracheo-bronchitis
Mycoplasma pneumoniae infection
erythromycin
